I am breaking with our standard newsletter format to share an incredible development in our 10 years of DADA2 research.

2024 marks ten years since researchers in Israel and the National Institutes of Health (NIH) in Bethesda, MD, first identified the genetic basis of Deficiency of Adenosine Deaminase 2 (DADA2). For many of us, however, that breakthrough in February 2014 was simply giving a name and genetic origin to a disease we had been living with for years.

The heat of Nashville’s summer has given way to the cooler temperatures of fall. Fall is always a time for me to reflect on where we have been and start thinking about where we are going. When I started the Foundation, it was with one goal in mind: to find a cure. The Foundation has successfully built an engaged network of patients, families, physicians and researchers, pushing our understanding of the disease forward in leaps and bounds. What do we need now? To be blunt, money. We will need to raise money – big and small amounts – to reach our goal.

The communities we build around us are powerful. This month, we’re sharing stories about how we’ve come together as a community to make life better for patients through research, as well as quick and thorough clinical care. I would also love to hear your thoughts on what we should highlight in future newsletters or on social media that furthers our mission to convene, collaborate and communicate to find a cure.

Take a look at the sheer volume of effort displayed this month to cure DADA2. There are talks given around the world every month and multiple monthly publications in journals that are widely read and respected. To each of you who is taking the time to invest in the research, presenting, and publishing, thank you!

When is the last time you told your DADA2 story to someone new? Maybe it was your diagnosis story to a new friend, or your career path to the lab work that is focused on DADA2? We all have a story to tell.

This month, we told our story far and wide, to the greatest leaders and to our everyday communities. Dr. Pui Lee traveled to Tunisia in East Africa this month to share about DADA2 with a large Pediatric Rheumatology Congress.

I’ll keep my intro this month short and sweet: Collaboration is Key. Below are a number of updates that illustrate this long known truth that we know changes lives.

In particular, I want to emphasize the incredibly important role that physicians play in collaboration today and especially in the future. It is YOUR interactions with patients that will help fuel the next wave of discovery for DADA2.

Dear DADA2 Community:

It is Rare Disease Day next week. This is THE time to honor each of our journeys – hard fought and challenging, but unique and inspiring!

Dear DADA2 Community, Welcome to this new year! As I mentioned at the end of last year, 2024 will be momentous. We have so much in the works that we are excited to share in due time. For now, I want to say thank you to every one of you who donated to the DADA2…

Dear DADA2 Community,

This may well be the most intellectually stimulating, time consuming, and absolutely fascinating newsletter we may ever send – that is, until the physicians and researchers meet again in 2025 for the 5th International Conference on DADA2.

Dear DADA2 Community,

What happens when you get nearly 100 scientists and clinicians in a room for 36 hours to share their latest findings and questions on DADA2?

Well, you get 30+ talks updating on the science and clinical news. You get 10+ posters that generate hours of discussion among scientists and doctors alike. You get side conversations and pages of notes and agreements to follow up, join efforts, and continue to pursue treatments and a cure.

Highlights of this month’s newsletter include:

• What Can You Do to Celebrate Rare Disease Day?
• Patient Registry Sneak Peek
• Feature on DADA2 Patient, Andy Grundstad
• Global Reach: Who’s Engaged in DADA2?

Highlights of this month’s newsletter include:

• The DADA2 Foundation is Grateful for Your Support
• Mutations and What Do They Mean?
• Patient Update: Adela Wee

Highlights of this month’s newsletter include:

• 2022 Year-End Recap
• 4th International Conference on DADA2 planned for 2023

Highlights of this month’s newsletter include:

• Identical Twins with DADA2: Anna Maria Beretta and Veronica Beretta
• Reminders for 2023 – Patient Registry, Conference, and New Website
• What Will You Do With Your DADA2 Story?

Highlights of this month’s newsletter include:

• Global Team Continues to Work on Consensus Statement
• Saudi Arabian Cohort: Study by Pediatric Hematologist, Dr. Fahad Alabbas
• What happens when a lifelong dream collides with your own diagnosis of DADA2?

Highlights of this month’s newsletter include:

• CZI Cohort Gathering
• Gene Therapy Progress
• DADA2 Family rallies local high school to raise funds with bake sale

Highlights of this month’s newsletter include:

• Meet Julie Williams, Genetic Counselor who will develop the DADA2 Patient Registry
• Meet Dr. Pui Lee, DADA2 physician and researcher at Boston Children’s Hosptial
• Meet Dr. Amanda Ombrello, DADA2 physician and researcher at the National Institutes of Health, Washington, DC
• Where in the world is DADA2 being studied?

Highlights of this month’s newsletter include:

• DADA2 Foundation Founder Dr. Chip Chambers will be the keynote speaker at the Nationwide Children’s Hospital virtual event
• Join us to raise awareness on Rare Disease Day 2022

Highlights of this month’s newsletter include:

• DADA2 Foundation’s Natural History Study (NHS) and Patient Registry (PR)
• Dr. Dan Kastner and Dr. Pui Lee provide insight on the importance of natural history studies
• What Patients Need to Know… about The Natural History Study & Patient Registry

Highlights of this month’s newsletter include:

• Momentum Report Highlights
• A Note From Our Founder, Chip Chambers, M.D.
• Supporting Each Other: Private Facebook Families & Friends Page